| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Telix Pharmaceuticals Ltd | MD & Group CEO, Director | Ordinary Shares | 20,675,000 | $155,476,000 | $7.52 | 18 Mar 2026 | Elk River Holdings Pty Ltd |
| Telix Pharmaceuticals Ltd | MD & Group CEO, Director | Ordinary Shares | 254,006 | $1,910,125 | $7.52 | 18 Mar 2026 | Direct |
| Telix Pharmaceuticals Ltd | MD & Group CEO, Director | American Depositary Receipts | 400,000 | 18 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TLX | Telix Pharmaceuticals Ltd | 18 Mar 2026 | 0 | $0 | 3 | MD & Group CEO, Director | 18 Mar 2026, 20:45 |